Cargando…

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease

Diabetes mellitus is a global health issue and main cause of chronic kidney disease. Both diseases are also linked through high cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) is present in up to 40% of diabetic patients; therefore, prevention and treatment of DKD are of utmost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vodošek Hojs, Nina, Bevc, Sebastjan, Ekart, Robert, Piko, Nejc, Petreski, Tadej, Hojs, Radovan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230766/ https://www.ncbi.nlm.nih.gov/pubmed/34208285 http://dx.doi.org/10.3390/ph14060561

Ejemplares similares

Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk
por: Piko, Nejc, et al.
Publicado: (2021)

Review on Inflammation Markers in Chronic Kidney Disease
por: Petreski, Tadej, et al.
Publicado: (2021)

Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy
por: Vodošek Hojs, Nina, et al.
Publicado: (2020)

Higher Body Mass Index is associated with increased arterial stiffness prior to target organ damage: a cross-sectional cohort study
por: Piko, Nejc, et al.
Publicado: (2023)

Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
por: Petreski, Tadej, et al.
Publicado: (2020)

The Role of Oxidative Stress in Kidney Injury
por: Piko, Nejc, et al.
Publicado: (2023)

Statin-Associated Necrotizing Myopathy Leading to Acute Kidney Injury: A Case Report
por: Petreski, Tadej, et al.
Publicado: (2021)

Biomarkers of Renal Disease and Progression in Patients with Diabetes
por: Hojs, Radovan, et al.
Publicado: (2015)

Serum zinc values, ankle brachial index and mortality in hemodialysis patients
por: Maša, Knehtl, et al.
Publicado: (2022)

Correction: Serum zinc values, ankle brachial index and mortality in hemodialysis patients
por: Knehtl, Maša, et al.
Publicado: (2022)

The association between pulse wave analysis, carotid-femoral pulse wave velocity and peripheral arterial disease in patients with ischemic heart disease
por: Piko, Nejc, et al.
Publicado: (2021)

Polymorphism in the GATM Locus Associated with Dialysis-Independent Chronic Kidney Disease but Not Dialysis-Dependent Kidney Failure
por: Šalamon, Špela, et al.
Publicado: (2021)

Polypharmacy and Mental Health Issues in the Senior Hemodialysis Patient
por: Knehtl, Maša, et al.
Publicado: (2022)

Simple Cystatin C Formula for Estimation of Glomerular Filtration Rate in Overweight Patients with Diabetes Mellitus Type 2 and Chronic Kidney Disease
por: Bevc, Sebastjan, et al.
Publicado: (2012)

Blue Woman Syndrome and Thyrotoxicosis in a Patient on Amiodarone
por: Petreski, Tadej, et al.
Publicado: (2020)

Gangrenous appendicitis presenting as acute abdominal pain in a patient on automated peritoneal dialysis: a case report
por: Ekart, Robert, et al.
Publicado: (2012)

A Case of ‘Sweet’ Hydrothorax in a Patient on Peritoneal Dialysis
por: Piko, Nejc, et al.
Publicado: (2019)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2021)

Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
por: Mende, Christian W., et al.
Publicado: (2023)

PB2050: EVALUATION OF NON-CLONAL ERYTHROCYTOSIS: SINGLE CENTRE EXPERIENCE
por: Šumah, A., et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease
por: Baran, Wiktoria, et al.
Publicado: (2021)

Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
por: Kim, Dong-Lim, et al.
Publicado: (2023)

Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease
por: Wu, Yichuan, et al.
Publicado: (2022)

Why are mineralocorticoid receptor antagonists cardioprotective?
por: Chai, Wenxia, et al.
Publicado: (2006)

Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus
por: Wish, Jay B., et al.
Publicado: (2022)

Simply adding oral nutritional supplementation to haemodialysis patients may not be enough: a real-life prospective interventional study
por: Ocepek, Andreja, et al.
Publicado: (2023)

Mineralocorticoid receptor antagonists in cardiovascular translational biology
por: Chilton, Robert J., et al.
Publicado: (2023)

Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease
por: Shah, Monarch, et al.
Publicado: (2023)

The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic  Nephropathy
por: Goenka, Luxitaa, et al.
Publicado: (2019)

Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes
por: DeFronzo, Ralph A., et al.
Publicado: (2022)

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
por: Kolkhof, Peter, et al.
Publicado: (2017)

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
por: Folkerts, Kerstin, et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future Challenges
por: Fujii, Wataru, et al.
Publicado: (2023)

The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone
por: Heinig, Roland, et al.
Publicado: (2023)

Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
por: Sun, Li‐Jing, et al.
Publicado: (2017)

Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
por: Funder, John W
Publicado: (2013)

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
por: Yugar-Toledo, Juan Carlos, et al.
Publicado: (2017)

Mineralocorticoid Receptor Antagonism in Chronic Kidney Disease
por: Georgianos, Panagiotis I., et al.
Publicado: (2021)

Potential Impact of Non-Steroidal Mineralocorticoid Receptor Antagonists in Cardiovascular Disease
por: Rahman, Asadur, et al.
Publicado: (2023)

Mineralocorticoid Receptor Antagonists in High‐Risk Heart Failure Patients With Diabetes Mellitus and/or Chronic Kidney Disease
por: Pitt, Bertram, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nelrl45o6qr0rbicp0nnlfbk82